 |
 |
Can anyone let me known the current status and practicality of measurement of procalcitonin as an infection marker in chronic lung disease? Regards, Trevor Tickner P.S. To those who sent thoughts on the low sodium case, many thanks. I am passing them back to clinical team for their further thoughts. This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed. If you have received this email in error please notify the originator of the message. This footer also confirms that this email message has been scanned for the presence of computer viruses but this should not be relied upon as a guarantee that the contents are virus free. Any views expressed in this message are those of the individual sender, except where the sender specifies and with authority, states them to be the views of the Norfolk and Norwich University Hospital NHS Trust. The information contained in this e-mail may be subject to public disclosure under the Freedom of Information Act 2000. Unless the information is legally exempt from disclosure, the confidentiality of this e-mail and your reply cannot be guaranteed ------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/